Table 4.
Combination treatment by targeting drug-induced autophagy in clinical trials for cancer therapy.
| Phase | Drug name | Targeting cancer cells | Autophagy inhibitor | References |
|---|---|---|---|---|
| I | Temozolomide | Melanoma and advanced solid tumors | HCQ | (Rangwala et al., 2014) |
| I/II | Temozolomide | Glioblastoma | HCQ | (Rosenfeld et al., 2014) |
| I | Doxorubicin | Advanced solid tumors | Pantoprazole | (Brana et al., 2014) |
| I | Doxorubicin | Lymphoma | HCQ | (Barnard et al., 2014) |
| I | Bortezomib | Myeloma | HCQ | (Vogl et al., 2014) |
| I | Temsirolimus | Melanoma | HCQ | (Rangwala et al., 2014) |
| I | Vorinostat | Advanced solid tumors | HCQ | (Mahalingam et al., 2014) |
HCQ, hydroxychloroquine.